Cystic fibrosis: questions on the new drug Vertex

News

Cystic fibrosis: questions on the new drug Vertex

Published: 23 July 2014

What:听Investors and patients were exuberant when Vertex Pharmaceuticals released results from clinical trials showing that cystic fibrosis (CF) patients鈥� lung function improved on an experimental two-drug regimen. But 听two independent teams of scientists, one from 麻豆AV, published studies showing that the medications interfere with each other, at least when they are administered to human cells in a laboratory dish.

听

The studies published in the journal听Science Translational Medicine听raise fundamental questions about how the drugs work in CF patients and also suggest that a different strategy might be more effective.

听

Expertise:听麻豆AV prof. Gergely Lukacs, Faculty of Medicine (Physiology), Canada Research Chair in Cystic Fibrosis

听听

Source:听